Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.

UniProtKB - P48061 (SDF1_HUMAN)

(max 400 entries)x

Your basket is currently empty. i

Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)

Protein

Stromal cell-derived factor 1

Gene

CXCL12

Organism
Homo sapiens (Human)
Status
Reviewed-Annotation score: -Experimental evidence at protein leveli

Functioni

Chemoattractant active on T-lymphocytes and monocytes but not neutrophils. Activates the C-X-C chemokine receptor CXCR4 to induce a rapid and transient rise in the level of intracellular calcium ions and chemotaxis. SDF-1-beta(3-72) and SDF-1-alpha(3-67) show a reduced chemotactic activity. Binding to cell surface proteoglycans seems to inhibit formation of SDF-1-alpha(3-67) and thus to preserve activity on local sites. Also binds to atypical chemokine receptor ACKR3, which activates the beta-arrestin pathway and acts as a scavenger receptor for SDF-1. Binds to the allosteric site (site 2) of integrins and activates integrins ITGAV:ITGB3, ITGA4:ITGB1 and ITGA5:ITGB1 in a CXCR4-independent manner (PubMed:29301984). Acts as a positive regulator of monocyte migration and a negative regulator of monocyte adhesion via the LYN kinase. Stimulates migration of monocytes and T-lymphocytes through its receptors, CXCR4 and ACKR3, and decreases monocyte adherence to surfaces coated with ICAM-1, a ligand for beta-2 integrins. SDF1A/CXCR4 signaling axis inhibits beta-2 integrin LFA-1 mediated adhesion of monocytes to ICAM-1 through LYN kinase. Inhibits CXCR4-mediated infection by T-cell line-adapted HIV-1. Plays a protective role after myocardial infarction. Induces down-regulation and internalization of ACKR3 expressed in various cells. Has several critical functions during embryonic development; required for B-cell lymphopoiesis, myelopoiesis in bone marrow and heart ventricular septum formation. Stimulates the proliferation of bone marrow-derived B-cell progenitors in the presence of IL7 as well as growth of stromal cell-dependent pre-B-cells (By similarity).By similarity7 Publications

Sites

Feature keyPosition(s)DescriptionActionsGraphical viewLength
Sitei45Important for integrin interaction and activation1 Publication1
Sitei46Important for dimer formation1
Sitei48Important for integrin interaction and activation1 Publication1
Binding sitei62Heparin1
Sitei64Important for integrin interaction and activation1 Publication1
Binding sitei69Heparin1
Binding sitei85Heparin1

GO - Molecular functioni

  • chemoattractant activity Source: GO_Central
  • chemokine activity Source: UniProtKB
  • chemokine receptor binding Source: UniProtKB
  • CXCR chemokine receptor binding Source: BHF-UCL
  • growth factor activity Source: UniProtKB-KW
  • integrin binding Source: UniProtKB
  • signaling receptor binding Source: ProtInc
View the complete GO annotation on QuickGO ...

GO - Biological processi

  • adult locomotory behavior Source: Ensembl
  • animal organ regeneration Source: Ensembl
  • antimicrobial humoral immune response mediated by antimicrobial peptide Source: UniProtKB
  • axon guidance Source: GO_Central
  • blood circulation Source: ProtInc
  • cell adhesion Source: ProtInc
  • cell chemotaxis Source: UniProtKB
  • cellular calcium ion homeostasis Source: ProtInc
  • chemokine-mediated signaling pathway Source: BHF-UCL
  • chemotaxis Source: UniProtKB
  • defense response Source: InterPro
  • detection of mechanical stimulus involved in sensory perception of pain Source: Ensembl
  • detection of temperature stimulus involved in sensory perception of pain Source: Ensembl
  • G-protein coupled receptor signaling pathway Source: Reactome
  • immune response Source: ProtInc
  • induction of positive chemotaxis Source: GO_Central
  • integrin activation Source: UniProtKB
  • killing of cells of other organism Source: UniProtKB
  • negative regulation of dendritic cell apoptotic process Source: BHF-UCL
  • negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage Source: BHF-UCL
  • negative regulation of leukocyte tethering or rolling Source: UniProtKB
  • neuron migration Source: Ensembl
  • positive regulation of axon extension involved in axon guidance Source: Ensembl
  • positive regulation of calcium ion import Source: BHF-UCL
  • positive regulation of cell adhesion Source: MGI
  • positive regulation of dopamine secretion Source: Ensembl
  • positive regulation of endothelial cell proliferation Source: Ensembl
  • positive regulation of monocyte chemotaxis Source: UniProtKB
  • positive regulation of T cell migration Source: MGI
  • regulation of actin polymerization or depolymerization Source: ProtInc
  • response to heat Source: Ensembl
  • response to hypoxia Source: Ensembl
  • response to peptide hormone Source: Ensembl
  • response to radiation Source: Ensembl
  • response to ultrasound Source: Ensembl
  • response to virus Source: ProtInc
  • signal transduction Source: ProtInc
  • T cell chemotaxis Source: UniProtKB
  • telencephalon cell migration Source: Ensembl
View the complete GO annotation on QuickGO ...

Keywordsi

Molecular functionCytokine, Growth factor
Biological processChemotaxis, Host-virus interaction

Enzyme and pathway databases

ReactomeiR-HSA-1251985 Nuclear signaling by ERBB4
R-HSA-376176 Signaling by ROBO receptors
R-HSA-380108 Chemokine receptors bind chemokines
R-HSA-418594 G alpha (i) signalling events
R-HSA-9018519 Estrogen-dependent gene expression
SIGNORiP48061

Names & Taxonomyi

Protein namesi
Recommended name:
Stromal cell-derived factor 1
Short name:
SDF-1
Short name:
hSDF-1
Alternative name(s):
C-X-C motif chemokine 12
Intercrine reduced in hepatomas
Short name:
IRH
Short name:
hIRH
Pre-B cell growth-stimulating factor
Short name:
PBSF
Cleaved into the following 2 chains:
SDF-1-beta(3-72)
SDF-1-alpha(3-67)
Gene namesi
Name:CXCL12
Synonyms:SDF1, SDF1A, SDF1B
OrganismiHomo sapiens (Human)
Taxonomic identifieri9606 [NCBI]
Taxonomic lineageiEukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo
Proteomesi
  • UP000005640 Componenti: Chromosome 10

Organism-specific databases

EuPathDBiHostDB:ENSG00000107562.16
HGNCiHGNC:10672 CXCL12
MIMi600835 gene
neXtProtiNX_P48061

Subcellular locationi

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionGraphics by Christian Stolte; Source: COMPARTMENTS

Keywords - Cellular componenti

Secreted

Pathology & Biotechi

Mutagenesis

Feature keyPosition(s)DescriptionActionsGraphical viewLength
Mutagenesisi22 – 23Missing : Abolished CXCR4 activation ability, but only slightly impaired binding to the receptor. 1 Publication2
Mutagenesisi22K → A: Loss of chemotactic activity. 2 Publications1
Mutagenesisi22K → R: Abolished CXCR4 activation ability, but only slightly impaired binding to the receptor. 2 Publications1
Mutagenesisi22Missing : Abolished CXCR4 activation ability, but only slightly impaired binding to the receptor. 2 Publications1
Mutagenesisi23P → G: Abolished CXCR4 activation ability, but only slightly impaired binding to the receptor. 1 Publication1
Mutagenesisi25 – 27SLS → AQA: Significantly impaired CXCR4 activation ability, but only slightly impaired binding to the receptor. 1 Publication3
Mutagenesisi28Y → A: Impaired CXCR4 activation ability, but only slightly impaired binding to the receptor. 1 Publication1
Mutagenesisi28Y → H: No significant effect on CXCR4 binding or activation. 1 Publication1
Mutagenesisi29R → K: Slightly impaired binding and activation of CXCR4. 2 Publications1
Mutagenesisi29R → Q: Greatly impaired chemotactic activity and enhanced inhibition by heparin. 2 Publications1
Mutagenesisi33 – 38RFFESH → AAAAAA: Significantly decreased chemotactic activity. 1 Publication6
Mutagenesisi33R → A: Significantly decreased anti-HIV-1 and chemotactic activities. 2 Publications1
Mutagenesisi33R → Q: Slightly impaired chemotactic activity and enhanced inhibition by heparin. Greatly impaired chemotactic activity; when associated with Q-29. 2 Publications1
Mutagenesisi34F → A: No effect on anti-HIV-1 and chemotactic activities. Slightly impaired chemotactic activity and no effect on inhibition by heparin; when associated with A-35. 1 Publication1
Mutagenesisi35F → A: No effect on anti-HIV-1 and chemotactic activities. Slightly impaired chemotactic activity and no effect on inhibition by heparin; when associated with A-34. 1 Publication1
Mutagenesisi36 – 38ESH → QSN: Slightly impaired chemotactic activity, no effect on inhibition by heparin. 1 Publication3
Mutagenesisi36E → A: No effect on anti-HIV-1 and chemotactic activities. 1 Publication1
Mutagenesisi37S → A: No effect on anti-HIV-1 and chemotactic activities. 1 Publication1
Mutagenesisi38H → A: No effect on anti-HIV-1 and chemotactic activities. 1 Publication1
Mutagenesisi41R → A: No effect on CXCR4 activation. 1 Publication1
Mutagenesisi45 – 48KHLK → SSLS: Loss of heparin-binding capacity. 1 Publication4
Mutagenesisi45K → E: Loss of integrin activation; when associated with E-48 or E-64. 1 Publication1
Mutagenesisi46H → A: Reduced dimerization in neutral pH. Eliminates the pH dependence of dimerization. 3 Publications1
Mutagenesisi46H → L: No significant effect on dimerization in neutral pH. Eliminates the pH dependence of dimerization. 3 Publications1
Mutagenesisi46H → N: Slightly impaired CXCR4 activation and clear resistance to inhibition by heparin; when associated with Q-48; Q-62; Q-68 and N-69. 3 Publications1
Mutagenesisi46H → R: No effect on CXCR4 activation. Impaired dimer formation, leading to increased chemotactic activity. Eliminates the pH dependence of dimerization. 3 Publications1
Mutagenesisi48K → A: Impaired CXCR4 activation. 2 Publications1
Mutagenesisi48K → E: Impaired CXCR4 activation. Loss of integrin activation; when associated with E-45 or E-64. 3 Publications1
Mutagenesisi48K → Q: Slightly impaired CXCR4 activation and clear resistance to inhibition by heparin; when associated with N-46; Q-62; Q-68 and N-69. 2 Publications1
Mutagenesisi52 – 56TPNCA → GPGCG: Slightly impaired chemotactic activity, no effect on inhibition by heparin. 1 Publication5
Mutagenesisi57L → C: Formation of an intermolecular disulfide bond, leading to a locked dimer; when associated with C-86. No effect on CXCR4 activation, but loss of chemotactic activity; when associated with C-86. 1
Mutagenesisi60V → A: Impaired CXCR4 activation. 1 Publication1
Mutagenesisi62R → A: No effect on CXCR4 activation. 2 Publications1
Mutagenesisi62R → Q: Slightly impaired CXCR4 activation and clear resistance to inhibition by heparin; when associated with N-46; Q-48; Q-68 and N-69. 2 Publications1
Mutagenesisi64K → E: Loss of integrin activation; when associated with E-45 or E-48. 1 Publication1
Mutagenesisi68R → A: Impaired CXCR4 activation. 2 Publications1
Mutagenesisi68R → E: Greatly impaired CXCR4 activation. 2 Publications1
Mutagenesisi68R → Q: Slightly impaired CXCR4 activation and clear resistance to inhibition by heparin; when associated with N-46; Q-48; Q-62 and N-69. 2 Publications1
Mutagenesisi69Q → N: Slightly impaired CXCR4 activation and clear resistance to inhibition by heparin; when associated with N-46; Q-48; Q-62 and Q-68. 1 Publication1
Mutagenesisi70V → A: Impaired CXCR4 activation. 1 Publication1
Mutagenesisi81E → A: No effect on CXCR4 activation. 1 Publication1
Mutagenesisi84E → A: No effect on CXCR4 activation. 1 Publication1
Mutagenesisi85K → A: No effect on CXCR4 activation. 1 Publication1
Mutagenesisi86A → C: Formation of an intermolecular disulfide bond, leading to a locked dimer; when associated with C-57. No effect on CXCR4 activation, but loss of chemotactic activity; when associated with C-57. 1

Organism-specific databases

DisGeNETi6387
MalaCardsiCXCL12
OpenTargetsiENSG00000107562
PharmGKBiPA35602

Chemistry databases

ChEMBLiCHEMBL3286074
DrugBankiDB06822 Tinzaparin

Polymorphism and mutation databases

BioMutaiCXCL12
DMDMi1352728

PTM / Processingi

Molecule processing

Feature keyPosition(s)DescriptionActionsGraphical viewLength
Signal peptidei1 – 21Sequence analysisAdd BLAST21
ChainiPRO_000000510922 – 93Stromal cell-derived factor 1Add BLAST72
ChainiPRO_000000511024 – 93SDF-1-beta(3-72)Add BLAST70
ChainiPRO_000000511124 – 88SDF-1-alpha(3-67)Add BLAST65

Amino acid modifications

Feature keyPosition(s)DescriptionActionsGraphical viewLength
Disulfide bondi30 ↔ 55
Disulfide bondi32 ↔ 71

Post-translational modificationi

Processed forms SDF-1-beta(3-72) and SDF-1-alpha(3-67) are produced after secretion by proteolytic cleavage of isoforms Beta and Alpha, respectively. The N-terminal processing is probably achieved by DPP4. Isoform Alpha is first cleaved at the C-terminus to yield a SDF-1-alpha(1-67) intermediate before being processed at the N-terminus. The C-terminal processing of isoform Alpha is reduced by binding to heparin and, probably, cell surface proteoglycans.1 Publication

Keywords - PTMi

Disulfide bond

Proteomic databases

PaxDbiP48061
PeptideAtlasiP48061
PRIDEiP48061
ProteomicsDBi55853
55854 [P48061-2]
55855 [P48061-3]
55856 [P48061-4]
55857 [P48061-5]
55858 [P48061-6]

PTM databases

iPTMnetiP48061
PhosphoSitePlusiP48061

Miscellaneous databases

PMAP-CutDBiQ5IT36

Expressioni

Tissue specificityi

Isoform Alpha and isoform Beta are ubiquitously expressed, with highest levels detected in liver, pancreas and spleen. Isoform Gamma is mainly expressed in heart, with weak expression detected in several other tissues. Isoform Delta, isoform Epsilon and isoform Theta have highest expression levels in pancreas, with lower levels detected in heart, kidney, liver and spleen.1 Publication

Developmental stagei

Isoform Alpha is ubiquitously expressed in fetal tissues. Isoform Beta and isoform Delta have more limited expression patterns, with highest levels detected in fetal spleen and fetal liver, respectively. Isoform Gamma and isoform Theta are weakly detected in fetal kidney.1 Publication

Gene expression databases

BgeeiENSG00000107562
CleanExiHS_CXCL12
GenevisibleiP48061 HS

Organism-specific databases

HPAiCAB017564

Interactioni

Subunit structurei

Monomer or homodimer; in equilibrium. Dimer formation is induced by non acidic pH and the presence of multivalent anions, and by binding to CXCR4 or heparin. Monomeric form is required for full chemotactic activity and resistance to ischemia/reperfusion injury, whereas the dimeric form acts as a partial agonist of CXCR4, stimulating Ca2+ mobilization but with no chemotactic activity and instead acts as a selective antagonist that blocks chemotaxis induced by the monomeric form. Interacts with the N-terminus of ACKR3. Interacts with integrin subunit ITGB3 (via the allosteric site (site 2)) (PubMed:29301984).8 Publications
(Microbial infection) Interacts with molluscum contagiosum virus protein MC148.1 Publication

GO - Molecular functioni

  • chemoattractant activity Source: GO_Central
  • chemokine activity Source: UniProtKB
  • chemokine receptor binding Source: UniProtKB
  • CXCR chemokine receptor binding Source: BHF-UCL
  • growth factor activity Source: UniProtKB-KW
  • integrin binding Source: UniProtKB
  • signaling receptor binding Source: ProtInc
View the complete GO annotation on QuickGO ...

Protein-protein interaction databases

BioGridi112288, 6 interactors
DIPiDIP-391N
IntActiP48061, 6 interactors
MINTiP48061
STRINGi9606.ENSP00000379140

Chemistry databases

BindingDBiP48061

Structurei

Secondary structure

193
Legend: HelixTurnBeta strandPDB Structure known for this area
Show more details
Feature keyPosition(s)DescriptionActionsGraphical viewLength
Helixi24 – 26Combined sources3
Beta strandi27 – 29Combined sources3
Beta strandi31 – 34Combined sources4
Beta strandi36 – 38Combined sources3
Helixi41 – 43Combined sources3
Beta strandi44 – 49Combined sources6
Turni53 – 55Combined sources3
Beta strandi59 – 63Combined sources5
Turni64 – 66Combined sources3
Beta strandi69 – 72Combined sources4
Helixi79 – 86Combined sources8

3D structure databases

ProteinModelPortaliP48061
SMRiP48061
ModBaseiSearch...
MobiDBiSearch...

Miscellaneous databases

EvolutionaryTraceiP48061

Family & Domainsi

Region

Feature keyPosition(s)DescriptionActionsGraphical viewLength
Regioni29 – 33Receptor and heparin bindingCurated5
Regioni39 – 41Receptor binding3
Regioni41 – 51Heparin bindingAdd BLAST11
Regioni48 – 50Receptor binding3
Regioni60 – 70Receptor bindingAdd BLAST11

Motif

Feature keyPosition(s)DescriptionActionsGraphical viewLength
Motifi22 – 23Receptor activation motif2

Sequence similaritiesi

Belongs to the intercrine alpha (chemokine CxC) family.Curated

Keywords - Domaini

Signal

Phylogenomic databases

eggNOGiENOG410J1S5 Eukaryota
ENOG4112BS6 LUCA
GeneTreeiENSGT00390000014056
HOGENOMiHOG000220915
HOVERGENiHBG107437
InParanoidiP48061
KOiK10031
OMAiSTPNCAL
OrthoDBiEOG091G14JB
PhylomeDBiP48061
TreeFamiTF353159

Family and domain databases

CDDicd00273 Chemokine_CXC, 1 hit
InterProiView protein in InterPro
IPR001811 Chemokine_IL8-like_dom
IPR033899 CXC_Chemokine_domain
IPR036048 Interleukin_8-like_sf
PfamiView protein in Pfam
PF00048 IL8, 1 hit
SMARTiView protein in SMART
SM00199 SCY, 1 hit
SUPFAMiSSF54117 SSF54117, 1 hit

Sequences (7)i

Sequence statusi: Complete.

Sequence processingi: The displayed sequence is further processed into a mature form.

This entry describes 7 isoformsi produced by alternative splicing. AlignAdd to basket

Isoform Beta (identifier: P48061-1) [UniParc]FASTAAdd to basket
Also known as: SDF-1-beta(1-72), hSDF-1beta

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.

« Hide

        10         20         30         40         50
MNAKVVVVLV LVLTALCLSD GKPVSLSYRC PCRFFESHVA RANVKHLKIL 
        60         70         80         90 
NTPNCALQIV ARLKNNNRQV CIDPKLKWIQ EYLEKALNKR FKM
Length:93
Mass (Da):10,666
Last modified:February 1, 1996 - v1
Checksum:i505B5A29C2B44E8D
GO
Isoform Alpha (identifier: P48061-2) [UniParc]FASTAAdd to basket
Also known as: SDF-1-alpha(1-68), hSDF-1alpha

The sequence of this isoform differs from the canonical sequence as follows:
     90-93: Missing.

Show »
Length:89
Mass (Da):10,103
Checksum:i62B44E8D209C3A14
GO
Isoform Gamma (identifier: P48061-3) [UniParc]FASTAAdd to basket
Also known as: hSDF-1gamma, SDF-1g

The sequence of this isoform differs from the canonical sequence as follows:
     90-93: RFKM → GRREEKVGKKEKIGKKKRQKKRKAAQKRKN

Show »
Length:119
Mass (Da):13,705
Checksum:iC36297D68341B824
GO
Isoform Delta (identifier: P48061-4) [UniParc]FASTAAdd to basket
Also known as: hSDF-1delta

The sequence of this isoform differs from the canonical sequence as follows:
     89-93: KRFKM → NLISAAPAGKRVIAGARALHPSPPRACPTARALCEIRLWPPPEWSWPSPGDV

Show »
Length:140
Mass (Da):15,495
Checksum:i602BFEB309014ED2
GO
Isoform Epsilon (identifier: P48061-5) [UniParc]FASTAAdd to basket
Also known as: hSDFepsilon

The sequence of this isoform differs from the canonical sequence as follows:
     89-93: KRFKM → NC

Show »
Length:90
Mass (Da):10,192
Checksum:i7375C44E8D209C3A
GO
Isoform Theta (identifier: P48061-6) [UniParc]FASTAAdd to basket
Also known as: hSDFphi, hSDFtheta, Phi

The sequence of this isoform differs from the canonical sequence as follows:
     90-93: RFKM → IWLYGNAETSR

Show »
Length:100
Mass (Da):11,395
Checksum:iBEF2739B8E70BAAD
GO
Isoform 7 (identifier: P48061-7) [UniParc]FASTAAdd to basket

The sequence of this isoform differs from the canonical sequence as follows:
     39-93: VARANVKHLK...EKALNKRFKM → YCTCLIRVSF...VPGPVNLGKA

Note: Gene prediction based on EST data.
Show »
Length:103
Mass (Da):11,004
Checksum:i33B2517CA23D65D8
GO

Sequence cautioni

The sequence CAC10202 differs from that shown. Reason: Erroneous gene model prediction.Curated

Mass spectrometryi

Isoform Alpha : Molecular mass is 7959 Da from positions 22 - 89. Determined by ESI. 1 Publication
Isoform Alpha : Molecular mass is 7606 Da from positions 24 - 88. Determined by ESI. 1 Publication
Isoform Beta : Molecular mass is 8522 Da from positions 22 - 93. Determined by ESI. 1 Publication
Isoform Beta : Molecular mass is 8297 Da from positions 24 - 93. Determined by ESI. 1 Publication

Alternative sequence

Feature keyPosition(s)DescriptionActionsGraphical viewLength
Alternative sequenceiVSP_05478139 – 93VARAN…KRFKM → YCTCLIRVSFHGATPLTQGS WVLYSLSCAGGETGLREPGP MVSPRVESHQEGRLGVPGPV NLGKA in isoform 7. 1 PublicationAdd BLAST55
Alternative sequenceiVSP_04211889 – 93KRFKM → NLISAAPAGKRVIAGARALH PSPPRACPTARALCEIRLWP PPEWSWPSPGDV in isoform Delta. 1 Publication5
Alternative sequenceiVSP_04211989 – 93KRFKM → NC in isoform Epsilon. 1 Publication5
Alternative sequenceiVSP_00105690 – 93Missing in isoform Alpha. 6 Publications4
Alternative sequenceiVSP_04120990 – 93RFKM → GRREEKVGKKEKIGKKKRQK KRKAAQKRKN in isoform Gamma. 2 Publications4
Alternative sequenceiVSP_04212090 – 93RFKM → IWLYGNAETSR in isoform Theta. 1 Publication4

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
L36033 mRNA Translation: AAB39332.1
L36034 mRNA Translation: AAB39333.1
DQ345517 mRNA Translation: ABC69270.1
DQ345518 mRNA Translation: ABC69271.1
DQ345519 mRNA Translation: ABC69272.1
DQ345520 mRNA Translation: ABC69273.1
U16752 mRNA Translation: AAA97434.1
U19495 mRNA Translation: AAB40516.1
AY644456 mRNA Translation: AAT76437.1
AY874118 mRNA Translation: AAW82036.1
CR450283 mRNA Translation: CAG29279.1
AK292628 mRNA Translation: BAF85317.1
AK311814 mRNA Translation: BAG34757.1
AU120056 mRNA No translation available.
AY802782 Genomic DNA Translation: AAV49999.1
AL137026 Genomic DNA Translation: CAC10202.1 Sequence problems.
AL137026 Genomic DNA Translation: CAC10203.1
CH471160 Genomic DNA Translation: EAW86619.1
BC039893 mRNA Translation: AAH39893.1
CCDSiCCDS31186.1 [P48061-3]
CCDS44373.1 [P48061-1]
CCDS53527.1 [P48061-4]
CCDS60518.1 [P48061-7]
CCDS7207.1 [P48061-2]
PIRiG01540
RefSeqiNP_000600.1, NM_000609.6 [P48061-1]
NP_001029058.1, NM_001033886.2 [P48061-3]
NP_001171605.1, NM_001178134.1 [P48061-4]
NP_001264919.1, NM_001277990.1 [P48061-7]
NP_954637.1, NM_199168.3 [P48061-2]
UniGeneiHs.522891

Genome annotation databases

EnsembliENST00000343575; ENSP00000339913; ENSG00000107562 [P48061-2]
ENST00000374426; ENSP00000363548; ENSG00000107562 [P48061-3]
ENST00000374429; ENSP00000363551; ENSG00000107562 [P48061-1]
ENST00000395793; ENSP00000379139; ENSG00000107562 [P48061-7]
ENST00000395794; ENSP00000379140; ENSG00000107562 [P48061-4]
ENST00000395795; ENSP00000379141; ENSG00000107562 [P48061-7]
GeneIDi6387
KEGGihsa:6387
UCSCiuc001jbf.5 human [P48061-1]

Keywords - Coding sequence diversityi

Alternative splicing

Similar proteinsi

Entry informationi

Entry nameiSDF1_HUMAN
AccessioniPrimary (citable) accession number: P48061
Secondary accession number(s): B2R4G0
, E7EVL0, H7BYN8, Q2L985, Q2L986, Q2L988, Q5IT36, Q6ICW0, Q9H554
Entry historyiIntegrated into UniProtKB/Swiss-Prot: February 1, 1996
Last sequence update: February 1, 1996
Last modified: July 18, 2018
This is version 192 of the entry and version 1 of the sequence. See complete history.
Entry statusiReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Miscellaneousi

Keywords - Technical termi

3D-structure, Complete proteome, Reference proteome

Documents

  1. Human chromosome 10
    Human chromosome 10: entries, gene names and cross-references to MIM
  2. MIM cross-references
    Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot
  3. PDB cross-references
    Index of Protein Data Bank (PDB) cross-references
  4. SIMILARITY comments
    Index of protein domains and families

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health